Nykode Therapeutics AS (OSL:NYKD)

Nykode Therapeutics AS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	106.23	115.4	162.6	206.39	216.23	183.85
Trading Asset Securities	-	-	-	-	12.17	24.94
Cash & Short-Term Investments	106.23	115.4	162.6	206.39	228.4	208.8
Cash Growth	-27.88%	-29.03%	-21.21%	-9.64%	9.39%	555.64%
Accounts Receivable	-	-	-	2.54	23.75	18.75
Other Receivables	2.37	0.91	1.07	1.79	2.41	1.34
Receivables	2.37	0.91	1.07	4.33	26.16	20.09
Prepaid Expenses	-	0.76	2.01	1.15	1.3	0.15
Other Current Assets	-	-	-	-	-	-0
Total Current Assets	108.61	117.07	165.68	211.87	255.86	229.03
Property, Plant & Equipment	7.17	7.74	10.52	9.53	9.17	0.41
Other Intangible Assets	0.07	0.07	0.07	0.03	0.03	0.03
Long-Term Deferred Charges	-	-	-	-	0.48	0.55
Other Long-Term Assets	30.77	28.6	31.92	0.05	0.02	0.01
Total Assets	146.61	153.48	208.19	221.48	265.56	230.03
Accounts Payable	3.38	0.86	1.33	2.31	2.75	1.61
Accrued Expenses	-	3.62	6.08	7.58	9.3	9.68
Current Portion of Leases	1.24	1.29	1.46	1.15	1.35	0.28
Current Income Taxes Payable	0.02	0.02	-	0.08	0.03	-
Current Unearned Revenue	-	-	8.34	19.87	16.26	-
Other Current Liabilities	1.78	3.3	3.41	8	1.69	1.61
Total Current Liabilities	6.42	9.1	20.61	38.99	31.37	13.18
Long-Term Leases	2.04	2.15	4.27	4.37	5.82	0.01
Long-Term Deferred Tax Liabilities	3.33	5.2	12.05	21.08	29.4	31.13
Other Long-Term Liabilities	0.89	0.82	0	0.03	4.91	6.86
Total Liabilities	12.67	17.27	36.93	64.46	71.5	51.18
Common Stock	0.37	0.37	0.37	0.34	0.33	0.33
Additional Paid-In Capital	128.99	128.99	128.99	83.32	81.53	60.35
Retained Earnings	-10.39	-8.76	29.56	64.71	107.46	116.87
Comprehensive Income & Other	14.98	15.62	12.35	8.65	4.74	1.31
Shareholders' Equity	133.95	136.21	171.26	157.02	194.06	178.85
Total Liabilities & Equity	146.61	153.48	208.19	221.48	265.56	230.03
Total Debt	3.28	3.44	5.73	5.51	7.17	0.28
Net Cash (Debt)	102.96	111.96	156.88	200.87	221.23	208.51
Net Cash Growth	-27.58%	-28.63%	-21.90%	-9.20%	6.10%	556.60%
Net Cash Per Share	0.32	0.34	0.52	0.69	0.77	0.70
Filing Date Shares Outstanding	326.55	326.55	326.55	294.69	289.62	284.79
Total Common Shares Outstanding	326.55	326.55	326.55	294.69	289.62	284.79
Working Capital	102.19	107.97	145.07	172.89	224.49	215.85
Book Value Per Share	0.41	0.42	0.52	0.53	0.67	0.63
Tangible Book Value	133.88	136.14	171.19	156.99	194.02	178.82
Tangible Book Value Per Share	0.41	0.42	0.52	0.53	0.67	0.63
Machinery	-	5.02	4.97	3.44	1.46	0.2

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.